Benzphetamine
Top View
- Anti-Obesity Agents Reference Number: ERX.NSMN.06 Effective Date: 06/15 Revision Log Last Review Date: 09/16
- PAPER Pharmacotherapy for Obesity: a Quantitative Analysis of Four Decades of Published Randomized Clinical Trials
- List of Scheduling Actions, Controlled Substances And
- Weight Loss Agents Commext
- Emit® Drugs of Abuse Urine Assays Cross-Reactivity List
- The Diagnostic Use of Alternate Samples in Forensic Toxicology
- Core-Vista 1500 Urine Drugs of Abuse Specificity.Pdf
- NFL List of Prohibited Substances I. ANABOLIC AGENTS
- Prior Authorization Criteria Drug Class Antiobesity Agents
- PAPER Pharmacotherapy for Obesity: a Quantitative Analysis of Four Decades of Published Randomized Clinical Trials
- DIDREX - Benzphetamine Hydrochloride Tablet Pharmacia and Upjohn Company ------Didrex CIII Brand of Benzphetamine Hydrochloride Tablets
- Human Performance Drug Fact Sheets
- United States Patent [191 [11] Patent Number: 4,576,944 Lafon [45] Date of Patent: Mar
- Centre for Reviews and Dissemination
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- Didrex CIII Brand of Benzphetamine Hydrochloride Tablets
- Drugs of Abuse, a DEA Resource Guide (2020 Edition)
- The Non-Medical Use of Prescription Drugs Policy Direction Issues